"Als Akutkrankenhaus der Schwerpunktversorgung und akademisches Lehrkrankenhaus des Universitätsklinikums Hamburg-Eppendorf (UKE) bieten wir ein breites medizinisches Spektrum - weit über die Grenzen Lüneburgs hinaus."

During the past decade, Klinikum Lüneburg conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 4 clinical trials were completed, i.e. on average, 36.4% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Lüneburg" #1 sponsor was "Galapagos NV" with 3 trials, followed by "Janssen Research & Development, LLC" with 3 trials sponsored, "Janssen-Cilag Ltd." with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored and "Applied Molecular Transport" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Lüneburg" #1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator and "University of Luebeck" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Lüneburg" are "Ulcerative Colitis" (5 trials), "Crohn's Disease" (4 trials), "Crohn Disease" (2 trials), "Acute Respiratory Failure" (1 trials) and "Brain Ischemia With Non-valvular Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Klinikum Lüneburg" in a lesser frequency.

Most popular intervention types in "Klinikum Lüneburg" are "Drug" (12 trials), "Other" (5 trials), "Biological" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Filgotinib" (4 trials), "Guselkumab" (2 trials), "Guselkumab Dose 1" (2 trials) and "Guselkumab Dose 2" (2 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Lüneburg" are 15 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Klinikum Lüneburg". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 11 completed trials in Klinikum Lüneburg, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Lüneburg, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".

Klinikum Lüneburg has several departments that took part in Clinical trials: "Klinikum Lüneburg/Abteilung Gastroenterologie" - 2 trials